icon-folder.gif   Conference Reports for NATAP  
 
  5th IAS Conference on HIV Pathogenesis, Treatment and Prevention
July 19th-22nd 2009
Capetown, South Africa
Back grey_arrow_rt.gif
 
 
 
Potent Antiviral Activity of S/GSK1349572, A Next Generation Integrase Inhibitor (INI), in INI-Na´ve HIV-1-Infected Patients: ING111521 Protocol
 
 
  Reported by Jules Levin
5th Conference on HIV Pathogenesis, Treatment and Prevention 19-22 July 2009, Cape Town South Africa
 
Jay Lalezari, Louis Sloan, Edwin DeJesus, Trevor Hawkins, Lewis McCurdy, Ivy Song, Julie Borland, Richard Stroder, ShuguangChen, Yu Lou, Mark Underwood, Tamio Fujiwara, Stephen Piscitelli, Sherene Min ING111521 Investigators, GlaxoSmithKline, RTP, NC, USA, Shionogi & Co., Ltd., Osaka, Japan

image002.gif

image004.gif

image006.gif

image008.gif

image010.gif

image012.gif

image014.gif

image016.gif

image018.gif

image020.gif

image022.gif

image024.gif

image026.gif

image028.gif

image030.gif